Our Heritage

We have a strong pharmaceutical and engineering heritage dating back to the founding of the Sterling Drug API facility in Dudley, North East England, in 1969

Since then, our business has had many names and focuses but in 2016, we came full circle and formed Sterling Pharma Solutions, an independent organisation with a focus on excellent customer service.

Today, we have over 50 years’ experience in contract research, development and manufacturing, four facilities and over 750 employees.

Together our facilities in the UK and the US offer first-class small molecule API services for the full product lifecycle from pre-clinical to commercial manufacture. Most recently, we have also added a highly experienced team in ADC discovery and development services, offering our customers an even wider portfolio of expertise.

Timeline

2021

Sterling Pharma Solutions acquires ADC Bio site in Deeside, Wales, UK

2020

Sterling Pharma Solutions acquires Alcami’s site in Germantown, Wisconsin, US

2020

Completion of Material Science Centre

2019

Sterling Pharma Solutions is acquired by GHO Capital

2019

Sterling Pharma Solutions acquires CiVentiChem site in Cary, North Carolina, US

2019

Sterling Pharma Solutions wins a Queen’s Award for International Trade for Outstanding Short Term Growth in Overseas Sales

2019

Sterling Pharma Solutions celebrates UK facility’s 50th birthday

2016

Sterling Pharma Solutions formed through MBO

2015

Shasun merges with Strides to form Strides Shasun

2006

Shasun Pharma Solutions Ltd formed

2003

Rhodia Pharma Solutions formed

2000

Site acquired by Rhodia

1996

ChiRex established

1996

New development and pilot plant built

1994

Site acquired by Sanofi

1992

Biological Waste Water Treatment facility commissioned

1988

Sterling Drug purchased by Eastman Kodak

1969

Sterling Drug API facility established in Dudley, Northumberland

Service. Passion. Science.